Anxiety and panic disorders are among the most prevalent mental health conditions globally, often presenting with debilitating physical and psychological symptoms. When standard therapeutic interventions or primary antidepressant medications do not provide immediate or sufficient relief for acute symptoms, healthcare providers may turn to targeted, fast-acting pharmacological options.